REVVITY, INC. (RVTY) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$153.89

From 52W high−4.08%

Volume1.26M

Market cap$16.84B

P/E (TTM)71.9x

P/S (TTM)5.8x

Div yield0.14%

Key dataOct 19, 2026

Open

$153.89

From 52W high

−4.08%

Volume

1.26M

Market cap

$16.84B

ValuationView details →

P/E (Fwd)

26.1x

EV/EBITDA

25.0x

P/E (TTM)

71.9x

RSI (14)

60.1

MomentumView details →

1D Return

−1.11%

YTD Return

+58.42%

SummaryUpdated Jul 1, 2026

Revvity, Inc. (NASDAQ:RVTY) is a leading provider of scientific instruments, reagents, and diagnostic solutions serving the life sciences research and healthcare diagnostics markets worldwide. Founded in 1937 as PerkinElmer, the company underwent a strategic transformation in 2023, divesting its Analytical and Enterprise Solutions business and rebranding as Revvity to focus exclusively on life sciences and diagnostics. The company operates from its headquarters in Waltham, Massachusetts, and has evolved from a diversified analytical instruments manufacturer into a specialized healthcare technology company focused on advancing scientific discovery and improving patient outcomes through innovative diagnostic and research solutions.

Ask drillr about REVVITY, INC. →

ValuationView details →

P/E (Fwd)

26.1x

P/E (TTM)

71.9x

EV/EBITDA

25.0x

EV/Sales

6.6x

P/S (TTM)

5.8x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

52.11%

Net Margin

8.16%

EBITDA Margin

26.34%

ROE (TTM)

3.29%

ROA (TTM)

1.97%

Asset Turnover

0.24x

GrowthView details →

Revenue YoY

+4.05%

EPS YoY

−11.02%

FCF YoY

+11.21%

Revenue CAGR 3Y

−4.82%

EPS CAGR 3Y

−22.75%

EBITDA YoY

−6.68%

MomentumView details →

1D Return

−1.11%

YTD Return

+58.42%

1Y Return

+60.81%

RSI (14)

60.1

vs 50D SMA

+11.96%

vs 200D SMA

+40.10%

Capital & dividendView details →

Debt/Equity

0.46x

Current Ratio

1.80x

Quick Ratio

1.50x

Div Yield

0.14%

Div Rate

$0.21

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

$1.41

EPS Surprise

16.53%

Beats (12Q)

7/12

Next Q EPS Est

$1.62

Avg Surprise (4Q)

7.10%

Rev Surprise

1.14%

Financials snapshotView financials →

Revenue (TTM)

2.91B

Net Income (TTM)

237.55M

Op. CF (TTM)

629.03M

Next earningsNov 3, 2026 →

Latest newsMore news →

Revvity, Inc. announced it will release its third quarter 2026 financial results before market open on November 3, 2026, and host a conference call the same day.17d ago

Similar companies

Medpace Holdings, Inc.MEDP 安图生物603658.SH Charles River Laboratories International, Inc.CRL Exact Sciences CorporationEXAS Joinn Laboratories(China)Co.,Ltd.06127.HK 金域医学603882.SH Find similar companies →

Latest newsMore news →

Revvity, Inc. announced it will host its 2026 Investor Day on November 13, 2026, featuring presentations from senior management on business initiatives, operational achievements and financial outlook.13d ago Revvity, Inc. announced it will release its third quarter 2026 financial results before market open on November 3, 2026, and host a conference call the same day.17d ago